Omnicare Settles Fraud Charges For $49.5M

Law360, New York (November 14, 2006, 12:00 AM EST) -- Omnicare Inc., a leading provider of pharmaceutical care for the elderly, has agreed to pay $49.5 million to the federal government and 42 states to settle allegations that it overcharged Medicaid.

The settlement, which was announced Tuesday, comes out of a previously disclosed review in which the company was accused of substituting capsules for tablets of Ranitidine, a generic form of the heartburn drug Zantac; tablets instead of capsules of Fluoxetine, a generic form of the antidepressant Prozac; and two 7.5 mg tablets for a single...
To view the full article, register now.